Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
grade C 4.83 -0.82% -0.04
SBBP closed down 0.82 percent on Friday, January 18, 2019, on 21 percent of normal volume. It was able to find support at its 50 day moving average.
2 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical SBBP trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Support Bullish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 50 DMA Support Bullish -0.82%
Jan 17 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.82%
Jan 17 Wide Bands Range Expansion -0.82%
Jan 17 Overbought Stochastic Strength -0.82%
Jan 16 Stochastic Sell Signal Bearish -2.42%
Jan 16 50 DMA Support Bullish -2.42%

Older signals for SBBP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Is SBBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jan 17 NFLX, GPOR, OZK and NLS among notable after hour movers
Dec 19 Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk
Dec 19 Strongbridge Biopharma closes transaction with Novo Nordisk to transfer the rights to MACRILEN in U.S. and Canada
Dec 19 Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN™ (macimorelin) in the United States and Canada
Dec 18 Benzinga's Top Upgrades, Downgrades For December 18, 2018
Dec 18 Do Hedge Funds Love Strongbridge Biopharma plc (SBBP)?
Nov 27 Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes — New Research Emphasizes Economic Growth
Nov 20 Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV™, and Ketoconazole on Human Cortisol Production
Nov 5 Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
Nov 3 Strongbridge Biopharma, Inc (SBBP) CEO Matthew Pauls on Q3 2018 Results - Earnings Call Transcript
See more SBBP news...
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 3.82
Average Volume 239,413
200-Day Moving Average 5.6733
50-Day Moving Average 4.817
20-Day Moving Average 4.5345
10-Day Moving Average 4.855
Average True Range 0.2433
ADX 21.71
+DI 19.6297
-DI 16.5571
Chandelier Exit (Long, 3 ATRs ) 4.3801
Chandelier Exit (Short, 3 ATRs ) 4.5499
Upper Bollinger Band 5.2774
Lower Bollinger Band 3.7916
Percent B (%b) 0.7
BandWidth 32.766567
MACD Line 0.0812
MACD Signal Line 0.0218
MACD Histogram 0.0595
Fundamentals Value
Market Cap 170.67 Million
Num Shares 35.3 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -1.65
Price-to-Sales 139.82
Price-to-Book 21.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.06
Resistance 3 (R3) 5.05 4.98 5.02
Resistance 2 (R2) 4.98 4.92 4.98 5.00
Resistance 1 (R1) 4.90 4.88 4.94 4.91 4.99
Pivot Point 4.83 4.83 4.85 4.83 4.83
Support 1 (S1) 4.75 4.77 4.79 4.76 4.67
Support 2 (S2) 4.68 4.73 4.68 4.66
Support 3 (S3) 4.60 4.68 4.64
Support 4 (S4) 4.61